Baird Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.1M Sell
1,062,587
-2,311
-0.2% -$186K 0.11% 126
2026
Q1
$92.3M Sell
1,064,898
-28,277
-3% -$2.71M 0.14% 105
2025
Q4
$105M Buy
1,093,175
+12,356
+1% +$1.2M 0.16% 94
2025
Q3
$103M Sell
1,080,819
-7,037
-0.6% -$647K 0.17% 99
2025
Q2
$94.8M Buy
1,087,856
+2,458
+0.2% +$208K 0.17% 104
2025
Q1
$97.5M Buy
1,085,398
+107,768
+11% +$9.64M 0.19% 98
2024
Q4
$78.1M Buy
977,630
+56,034
+6% +$4.85M 0.15% 118
2024
Q3
$83M Sell
921,596
-119,915
-12% -$10.1M 0.16% 121
2024
Q2
$82M Buy
1,041,511
+30,603
+3% +$2.51M 0.17% 120
2024
Q1
$88.1M Buy
1,010,908
+146,872
+17% +$12.5M 0.18% 124
2023
Q4
$71.2M Buy
864,036
+34,653
+4% +$2.64M 0.16% 154
2023
Q3
$65M Sell
829,383
-48,851
-6% -$4.09M 0.18% 131
2023
Q2
$77.4M Buy
878,234
+25,026
+3% +$2.15M 0.2% 118
2023
Q1
$68.8M Buy
853,208
+357,083
+72% +$29.1M 0.17% 141
2022
Q4
$38.6M Sell
496,125
-292,984
-37% -$23.7M 0.1% 204
2022
Q3
$63.7M Buy
789,109
+9,068
+1% +$815K 0.19% 132
2022
Q2
$70M Sell
780,041
-30,577
-4% -$3.1M 0.19% 116
2022
Q1
$89.9M Buy
810,618
+36,436
+5% +$3.85M 0.22% 99
2021
Q4
$80.1M Sell
774,182
-49,387
-6% -$5.72M 0.19% 133
2021
Q3
$103M Buy
823,569
+26,396
+3% +$3.42M 0.26% 89
2021
Q2
$99M Sell
797,173
-22,403
-3% -$2.81M 0.26% 86
2021
Q1
$96.8M Sell
819,576
-23,773
-3% -$2.79M 0.27% 81
2020
Q4
$98.8M Buy
843,349
+26,555
+3% +$2.92M 0.3% 76
2020
Q3
$84.9M Buy
816,794
+13,387
+2% +$1.34M 0.29% 76
2020
Q2
$73.7M Buy
803,407
+367,416
+84% +$35.2M 0.28% 83
2020
Q1
$39.3M Buy
435,991
+35,352
+9% +$3.76M 0.18% 144
2019
Q4
$45.5M Buy
400,639
+20,863
+5% +$2.29M 0.16% 154
2019
Q3
$41.3M Buy
379,776
+56,658
+18% +$5.91M 0.16% 157
2019
Q2
$31.5M Buy
323,118
+67,721
+27% +$6.18M 0.12% 192
2019
Q1
$23.3M Buy
255,397
+3,338
+1% +$299K 0.14% 199
2018
Q4
$22.9M Buy
252,059
+25,673
+11% +$2.4M 0.16% 171
2018
Q3
$22.5M Buy
226,386
+7,307
+3% +$676K 0.14% 182
2018
Q2
$18.8M Sell
219,079
-7,131
-3% -$596K 0.13% 196
2018
Q1
$18.1M Buy
226,210
+33,179
+17% +$2.74M 0.13% 201
2017
Q4
$15.6M Buy
193,031
+80,880
+72% +$6.48M 0.11% 207
2017
Q3
$8.72M Buy
112,151
+3,999
+4% +$332K 0.07% 293
2017
Q2
$9.6M Buy
108,152
+1,185
+1% +$99.9K 0.08% 266
2017
Q1
$8.62M Buy
106,967
+6,632
+7% +$518K 0.07% 277
2016
Q4
$7.15M Sell
100,335
-56,413
-36% -$4.43M 0.06% 302
2016
Q3
$13.5M Buy
156,748
+1,188
+0.8% +$104K 0.12% 183
2016
Q2
$13.5M Buy
155,560
+26,707
+21% +$2.16M 0.12% 184
2016
Q1
$9.66M Buy
128,853
+24,218
+23% +$1.82M 0.09% 224
2015
Q4
$8.05M Buy
104,635
+160
+0.2% +$12K 0.08% 250
2015
Q3
$6.99M Buy
104,475
+3,466
+3% +$255K 0.07% 266
2015
Q2
$7.49M Buy
+101,009
New +$7.72M 0.07% 258

Other funds holding MDT

Baird Financial Group's MDT Position: Q2 2026 in Review

Baird Financial Group reduced its Medtronic (MDT) stake by 0.22% in Q2 2026, selling an estimated $186K and leaving 1,062,587 shares worth $83.1M. The position accounts for 0.11% of the portfolio, ranked #126.

Baird Financial Group first reported a position in MDT in Q2 2015 and has held it in 45 quarters since. The position peaked at $105M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Baird Financial Group held 1,062,587 shares of Medtronic worth $83.1M as of Q2 2026.
  • Baird Financial Group sold 2,311 Medtronic shares in Q2 2026, an estimated $186K.
  • Medtronic made up 0.11% of Baird Financial Group's portfolio in Q2 2026, its #126 holding.
  • Baird Financial Group first reported a position in Medtronic in Q2 2015 and has held it in 45 quarters since.
  • Baird Financial Group's Medtronic position peaked at $105M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.